Brand Description
A treatment for moderate-to-severe plaque psoriasis, ILUMYA (tildrakizumab-asmn) is an IL-23 inhibitor that offers patient support and clinical efficacy data.
Associated Domains
IAB Categories:
Health & Fitness
IAB Ad Products:
Health and Medical ServicesPharmaceuticals
IAB Categories:
Health & Fitness
IAB Ad Products:
Health and Medical ServicesPharmaceuticals
| ID | Domain | Seat | Bid | Timestamp | Status | Ad Format | Sub Format | Size | Quality Score | Data Transferred | Computational Cost |
|---|